Dementia Clinical Trials

Find Dementia Clinical Trials Near You

Intervention to Promote Communication Quality of Life for Persons With Language-Led Dementia and Their Partners: A Randomized Pilot Trial

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn whether a personalized, multi-component, virtual speech language treatment program can improve communication and quality of life for adults with primary progressive aphasia (PPA) and their primary communication partners. The study will enroll participants who speak English and/or Spanish. The main questions the study aims to answer are: * Is the telerehabilitation program feasible and acceptable for people with PPA and their study partners? * Do participants with PPA and study partners find treatment beneficial? * What patterns of treatment response are seen in participants? * Which outcome measures are most useful for evaluating changes in communication and quality of life? Researchers will compare participants who receive intervention immediately to participants assigned to a waitlist control group (who will receive treatment after a delay) to see whether participation in the treatment program is associated with improvements in communication and quality of life. Participants will: * Take part in speech language therapy sessions delivered by video visit that combine restorative, compensatory, and partner-focused communication strategies. Treatment may take place after a waiting period. * Receive education and communication training together with their partner. * Complete speech, language, and cognitive assessments. * Complete questionnaires about communication abilities, daily functioning, and quality of life.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: f
View:

• A PPA (Gorno-Tempini et al., 2011) or PPA-plus (Mesulam et al., 2001) diagnosis

• MMSE score of 15 or higher and must be able to produce single monosyllabic words intelligibly

• Must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)

• Hearing and vision adequate for participation in teleconference meetings

• Must have a study partner available (someone who will commit to attending teleconference sessions, as needed, during assessment and treatment phases)

• Partners must express willingness to attend and participate in assessment and treatment sessions, including those targeting dyadic communication goals

• Partners must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)

• Partner's hearing and vision should be adequate for participation in teleconference meetings

⁃ The participant and/or study partner must have basic experience using a computer.

Locations
United States
Texas
University of Texas
RECRUITING
Austin
Contact Information
Primary
Henry Lab Research Coordinator
aphasialab@austin.utexas.edu
512-471-3420
Backup
Grasso Lab Research Coordinator
multilingual.aphasia@austin.utexas.edu
512-232-1440
Time Frame
Start Date: 2026-04-01
Estimated Completion Date: 2027-08
Participants
Target number of participants: 30
Treatments
Other: Waitlist Control
Individuals in the waitlist-control group will undergo initial assessment followed by a waiting interval of 12 (Multi-VISTA) or 13 (Multi-LRCT) weeks. Following the waiting period, they will again complete baseline assessments prior to the treatment phase (co-development of training materials and Multi-VISTA or Multi-LRCT treatment).
Experimental: Immediate Treatment
Individuals in the immediate treatment group will undergo initial assessment followed immediately by the treatment phase (co-development of training materials and Multi-VISTA or Multi-LRCT treatment).
Sponsors
Leads: Maya Henry
Collaborators: National Institute on Aging (NIA), National Institutes of Health (NIH)

This content was sourced from clinicaltrials.gov